Penumbra, Inc. Reports First Quarter 2026 Financial Results
Go back to Penumbra, Inc. Reports First Quarter 2026 Financial Results| Boston Scientific (NYSE: BSX) | Delayed: 42.97 -0.22 (0.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.19 | 52 Week High | $24.79 | |||
| Open | $43.77 | 52 Week Low | $15.67 | |||
| Day High | $43.77 | P/E | N/A | |||
| Day Low | $42.69 | EPS | $-0.09 | |||
| Volume | 11,199,054 | |||||
| (NYSE: PEN) | Delayed: 316.50 -0.89 (0.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $317.39 | 52 Week High | $79.49 | |||
| Open | $318.37 | 52 Week Low | $40.23 | |||
| Day High | $318.37 | P/E | N/A | |||
| Day Low | $316.32 | EPS | $0.00 | |||
| Volume | 640,409 | |||||
